Skip to main content

Table 2 In vitro anti-proliferative effects (IC50, µM) of compounds 8a-l against A549, MDA-MB231 and MCF7 cell lines

From: Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations

Compound

R

A549

MDA-MB231

MCF7

8a

H

> 50

> 50

> 50

8b

3-CH3

> 50

> 50

29 ± 0.005

8c

4-CH3

> 50

> 50

25 ± 0.001

8d

3-OCH3

> 50

> 50

> 50

8e

4-OCH3

> 50

> 50

> 50

8f

3-F

> 50

> 50

> 50

8g

3-Cl

> 50

> 50

39.1 ± 0.001

8h

4-Cl

> 50

> 50

> 50

8i

4-Br

> 50

> 50

> 50

8j

3,4DiCl

> 50

> 50

> 50

8k

3-Cl-4-CH3

> 50

46 ± 0.003

> 50

8l

4-Cl-3-CF3

> 50

> 50

> 50

Etoposide

–

25.8 ± 0.0008

27.9 ± 0.002

29.8 ± 0.0007

  1. Values were the means of three replicates ± standard deviation (SD)